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Diagnosis and management of infectiveendocarditis have
significantly changed in the past 2S years. Improved
bacteriologic techniques have allowed detection of cases
of infective endocarditis caused by unusual organisms.
Bactericidal therapy has become available for patients
Infective endocarditis was described by Morgagni in the
mid 1700s (I). Rokitansky established its infectious etiology
during the mid 1800s by identifying microbes within veg-
etations at embolic sites (2). In 1869, Winge demonstrated
cocci in stained sections of lesions in patients with endo-
carditis (3). The bacterial etiology was established by Hei-
berg, Klebs and others (4-6).
On February 26. 1885, William Osler gave the first of
three Gulstonian lectures on malignant endocarditis. He be-
san. "It is of use, from time to time, to take stock, so to
speak, of our knowledge of a particular disease, to see
exactly where we stand in regard to it, to inquire to what
conclusions the accumulated facts seem to point, and to
iscertain in what direction we may look for fruitful inves-
igations in the future." In this and the following lectures
m March 3 and March 5, 1885. Osler presented a remark-
ible amount of clinical and pathologic data on the disease
ie termed malignant endocarditis. The reader is referred to
he recent informative scholarly observations of the Osler
Julsronlan lectures (7,8).
Half a century elapsed between Osler's Gulstonian lee-
ures in 1885 and the next major development in the history
If the disease. In 1937 sulfonamides were introduced. and
ilthough the cure rate was low. these agents represented the
irst step in the specific treatment of infective endocarditis
9). Penicillin, introduced in 1944. was the first effective
.ntimicrobial therapy for this disease (10-12).
It seems appropriate now. almost 100 years after the
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with gram-negative endocarditis and antimicrobial ther-
apy has improved. Echocardiography has become an
important diagnostic and management aid, and cardiac
valve replacement has dramatically improved the out-
look for many patients.
Gulstonian lectures and 25 years after the early antibiotic
era, to note the changes that have occurred. and in particular
the changes during the last quarter century. The changes
involve the spectrum of etiologic organisms causing infec-
tive endocarditis , changes in clinical presentation, new com-
plicating factors in disease causation, important additions
to laboratory investigations. significant changes in medical
antibiotic treatment and the addition of surgical treatment
in selected patients. In addition, the mean age of patients
has progressively increased from 40 to 42 years in the 1950s
to 50 to 54 years in the 19605, and the disease has become
increasingly common in patientsover 60 yearsof age (13,14).
Microbiologic Etiology of
Infective Endocarditis
Improved microbiologic techniques. Virtually any or-
ganism is capable of causing infective endocarditis (15-20) .
Table I compares the microbiologic cause of infective en-
docarditis in 172 patients seen at the Mayo Clinic from 1951
through 1957 with that in 393 patients treated at the Mayo
Clinic 20 years later. These data suggest that the micro-
biologic causes in the two periods differed. The increased
number of reports of previously uncommon causes of in-
fective endocarditis is probably attributable to two factors:
I) improved microbiologic techniques. and 2) a change in
the microbiologic spectrum. The impact of improved micro-
biologic techniques is apparent in patients with gram-neg-
ative bacilli, "other" infections and "culture-negative" en-
docarditis. Hemophilus parainfluenzae is a member of the
HACEK group of microorganisms, which are slow-grow-
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Table 1. Microbiologic Findings in Infective Endocarditis*
Finding (no .) (%j (no .) (%j
Viridans streptococci 91 53 149 39
Group 0 streptococci 28 16 79t 20
Staphylococcus aureus 24 14 72 18
S. epidermidis 4 2 16 4
Gram-negative bacilli 10 6 35 9
Other microorganisms I 1 29 7
Negative blood cultures 14 8 13 3
Total 172 100 393 100
' From Wilson WR. Giuliani ER. Geraci JE. Treatment of penicillin-sensitive
streptococcal infective endocarditis. Mayo Clin Proc 1982:57:81- 5.
t lncludcs 26 Streptococcus bovis isolates.
ing, fastidious gram-negative bacilli with special growth
requirements; the HACEK group includes Hemophilus sp,
Actinoba cillus actinomycetemcomitan s, Cardiobacterium
homini s, Eikenella corrodens and Kingella kingii . These
fastidious microorganisms constitute a major portion of the
gram-negative bacillary causes of infect ive endocarditis in
the later group of patients seen at the Mayo Clinic. A pro-
longed period of incubation , often 3 weeks or longer. is
frequently necessary to detect growth of these micro-
organisms in blood cultures. Because of the fastidious growth
requirements and prolonged incubation period , cases caused
by the HACEK group of microorganisms durin g the 1950s
were likel y to have been classified as " culture-negative"
endocarditis.
Durin g the 1970s, approximatel y 8% of cases of peni-
cillin-sensitive streptococcal infective endocarditis were
caused by nutr itional1y variant viridans streptococci. These
microorganisms require a pyridoxal-supplemented medium
for growth . Cases of infect ive endocarditis caused by nu-
tritional1y variant viridans streptococci were also likely to
have been classified as " culture-negative" during the 1950s.
Of the 29 patients seen durin g the 1970s with infective
endocarditis caused by "other" microorganisms. 8 had in-
fection s with anaerobic gram-pos itive cocci. In the 1950s.
anaerobi c microbiology was largely a research tool and pa-
tients with infective endocarditis caused by anaerobic bac-
teria would have been includ ed in the " culture-negative"
group.
Changing microbiologic spectrum. Although im-
proved techniques may expl ain some of the microbiologic
differences betwe en infective endocarditi s diagnosed durin g
the 1950s and that of the 1970s, the experien ces at the Mayo
Clinic and elsewhere indic ate that the bacteri al spectrum of
infecti ve endocarditis is changing. The percent of patient s
at the Mayo Clinic with endocarditi s caused by viridans
streptococci declined from 53% durin g the 1950s to 38%
in the 1970s. The average annual number of cases of in-
1951 to 1957
Patients
1970 to 1979
Patients
fective endocarditis incre ased from 24. 5 in the 1950s to 39
20 years later , and the number of patients with viridans
streptococcal infections increased from 13 a year in the
1950s to 15 a year in the 1970s. It is clear that there are
not fewer patients with viridans streptococcal endocarditis
but rather more patients with endocarditis caused by other
microorganisms. The change in the microbiologic spectrum
is partly a result of nosocomial1y acqu ired infection s as-
sociated with the increased use of intravascular prostheses
and invasive mechanical life support and monitoring sys-
tems. Another major factor responsible for the chan ge in
the microbiologic spectrum is the increased number of pa-
tients with infective endocarditis related to the intravenous
use of il1icit drugs . Nosocomial1y acquired or addict- asso-
ciated endocarditis is often caused by Staphylococcus epi -
dermidis , gram-negative bacilli, Candida and "opportun-
istic" microorgani sms-uncommon causes of infective
endocarditis in the 1950s.
Role of Blood Cultures in the Diagnosis of
Infective Endocarditis
Despite the changing spectrum of infective endocarditis, at
least 75% of infections are caused by streptococci or staph-
ylococci (15-20). During the 1950s. the majority of these
cases were readily diagnosed by routine blood culture sys-
tems . Improvement in microbiologic techn iques during the
1970s has largel y been respon sible for detection of cases
caused by unusual microorganism s.
In patients with suspected infecti ve endocarditi s , the most
important laboratory finding is the isolation of bacteria or
fungi from at least two or more blood cultures obtained at
intervals during a 48 hour period. During the 1940s, studies
performed by Beeson et al. (21) demonstrated that bacter-
emias associated with infective endocarditis are usually con-
tinuous. During the 1960s, Werner et al. (22) reported that
if any blood cultures are positive in patients with infective
endocarditi s. most of the other cultures drawn will also be
positi ve . Studies perform ed durin g the 1930s and later
( 17,22 ,23) indicated that the order of magnitude of bacter-
emia in patients with infective endocarditis is usuall y rel-
atively low . In 83% of cases , the quantitative blood cultures
contained less than 100 colonies/ml. In 1925, Wright (24)
was unable to document an association of bacteremia with
fever in patients with infective endocarditis . These early
studies and subsequent studies have shown that cultures of
peripheral venous blood are as likely to be positive as those
of arterial blood (2 1,24).
How many cultures are necessary? In 1956. Belli and
Waisbren (25) reported that 52 of 82 cases of infect ive
endocarditis were diagnosed from the first blood culture and
in only 6 cases were more than five blood cultures necessary .
More than 10 years later, Werner et al. (22) confirm ed this
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observation. They reported that streptococci were isolated
from the first blood culture in 96% of cases and from one
of the first two blood cultures in 98% of cases. Staphylococci
were isolated from the first culture in 90% of cases and
from one of the first two cultures in 100% of cases. Anti-
microbial therapy administered within 2 weeks before blood
cultures were obtained reduced the frequency of positive
cultures in cases of streptococcal endocarditis from 97 to
91% (p< 0.002) (22). In cases of endocarditis caused by
microorganisms other than streptococci or staphylococci,
the causative agent was isolated from the first blood culture
in 82% of cases and from one of the first two blood cultures
in 100% of cases (22).
From these studies, it is apparent that blood culture sys-
tems available for use in the 1950s were able to diagnose
the majority of cases of infective endocarditis and that im-
provements in microbiologic techniques have permitted de-
tection of cases caused by unusual microorganisms. These
earlier studies confirm recent observations that it is rarely
necessary to obtain more than three separate sets of blood
cultures within a 24 hour period in 2 consecutive days in
patients with suspected infective endocarditis.
Clinical Presentation
Prolonged duration of infection before diagnosis due
to partial treatment. The classic manifestations of patients
with streptococcal and staphylococcal endocarditis, such as
peripheral hypersensitivity, embolic phenomena and spleno-
megaly, have not changed appreciably since the 1950s. Other
features of infective endocarditis are quite different in pa-
tients seen today compared with those seen 25 years ago.
For example, the outpatient use of broad spectrum, orally
administered antimicrobial agents has resulted in an in-
creased frequency of partially treated cases of infective en-
docarditis. As a consequence, the duration of illness before
its diagnosis in patients with streptococcal endocarditis is
often prolonged. In our experience, 25 to 30% of patients
with viridans streptococcal or enterococcal endocarditis have
symptoms of infection for 3 months or longer before di-
agnosis. This prolonged period may increase complications
of infective endocarditis, such as valvular dysfunction and
large systemic peripheral emboli.
Role of prosthetic valves. Cardiac valve replacement
and the use of other intravascular prostheses have increased
dramatically during the last 25 years. The clinical presen-
tation of today's patient with endocarditis associated with
an intracardiac prosthesis differs from that of the 1950s'
patient with endocarditis. Today's patient frequently does
not present with the classic manifestations of infective en-
docarditis. Fever, relapsing bacteremia, congestive heart
failure and systemic embolization are more common than
manifestations of peripheral hypersensitivity, splenomegaly
and a new regurgitant murmur.
Endocarditis in drug addicts. A third major difference
between the presentation of today's patients with infective
endocarditis and that 25 years ago is associated with illicit
intravenous drug abuse. Infective endocarditis in drug ad-
dicts frequently involves the tricuspid valve and is often
caused by Candida, other fungi or gram-negative bacilli,
such as Pseudomonas or Serratia. Moreover, infections are
frequently polymicrobial. Patients with right-sided endo-
carditis or endocarditis caused by previously unusual gram-
negative bacilli often do not present with the manifestations
of endocarditis seen in patients with streptococcal or staph-
ylococcal infection. Additionally, these patients frequently
leave the hospital before completion of antimicrobial ther-
apy or resume drug abuse after dismissal, and multiple ep-
isodes of infective endocarditis are common. These features
of infective endocarditis were distinctly uncommon in pa-
tients during the 1950s.
Antimicrobial Therapy
Two versus four week treatment regimen. The anti-
microbial therapy of patients with viridans streptococcal,
enterococcal or staphylococcal endocarditis has not changed
appreciably in the last 25 years. During this time, many
authorities believed that patients with viridans streptococcal
endocarditis should be treated for 4 weeks with penicillin
G administered alone or in combination with streptomycin
for the first 2 weeks of therapy (25-29). In the late 1950s,
Geraci and Martin (30-32) and Tompsett et al. (33) sug-
gested that these patients could be treated successfully for
2 weeks with a combination of penicillin and streptomycin.
The short-term regimen did not gain wide acceptance until
the late 1970s and early 1980s. Additional published studies
substantiated the earlier observations and the 2 week regi-
men is now accepted as equivalent to a 4 week regimen for
the treatment of most patients with penicillin-sensitive vir-
idans streptococcal endocarditis (34-36). The 2 week reg-
imen is safe and effective for the majority of these patients
and is more cost effective than are the 4 week regimens.
Streptomycin-resistant enterococcaI endocarditis.
During the 1940s and 1950s, it was recognized that enter-
ococci are inhibited but not killed by penicillin G alone.
Penicillin combined with an aminoglycoside is necessary
for bactericidal activity against enterococci. For 25 years,
penicillin G and streptomycin administered for 4 to 6 weeks
was the standard form of therapy for patients with entero-
coccal endocarditis (37-39). In the early 1970s, it became
known that approximately one-third of streptococci exhibit
high level resistance in vitro to streptomycin. These entero-
cocci are not killed synergistically by the combination of
penicillin and streptomycin. Penicillin together with gen-
tamicin exerts a bactericidal synergistic effect against these
microorganisms. Most authorities now believe that patients
with streptomycin-resistant enterococcal endocarditis should
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be treated with a combination of penicillin and gentamicin
for 4 to 6 weeks (40,41).
Staphylococcal endocarditis. During the 1940s and early
1950s , the majority of isolates of Staphylococcal aureus
were susceptible to penicillin. Now, virtually all isolates of
S. aureus produce beta lactamase and are resistant to pen-
icillin G. Methicillin was introduced during the 1950s and
the use of semisynthetic beta lactamase-resistant penicillins
is now widely accepted as standard antimicrobial therapy
for patients with S. aureus endocarditis . Use of methicillin
may be associated with nephritis, and many authorities now
consider methicillin of historic interest. NafciIIin, oxacillin.
vancomycin and the cephalosporins have replaced methi-
cillin for the treatment of patients with staphylococcal en-
docarditis. Endocarditis caused by Staphylococcal epider-
midis was uncommon during the 1950s. However, because
of the increased use of intravascular prostheses. endocarditis
caused by this microorganism is now relatively common.
During the last 25 years, the majority of strains of S. epi-
dermidis have acquired resistance to methicillin , and a com-
bination of vancomycin. rifampin and possibly gentamicin
is now considered optimal therapy for patients with endo-
carditis caused by S. epidermidis .
Gram-negative bacillary endocarditis. The antimicro-
bial therapy for patients with endocarditis caused by gram-
negative bacilli has also changed dramatically in the last 25
years with the introduction of aminoglycosides, such as
gentamicin and amikacin and broad spectrum cephalospo-
rins . Bactericidal therapy for patients with gram-negative
endocarditis was not available during the 1950s. As dis-
cussed later, advances in the technique of cardiac valve
replacement have greatly improved the prognosis of patients
with gram-negative bacillary endocarditis and endocarditis
from other causes.
Echocardiography
In the past decade, the development of echocardiography
has had a significant impact on the diagnosis and man-
agement of infective endocarditis . The value of echocar-
diography in the evaluation of functional cardiac anatomy
and cardiac disease was first reported by Edler and Hertz
(42) . Dillon et aI. (43) were the first to report the value of
M-mode echocardiography in the diagnosis of bacterial en-
docarditis. Their study included eight patients, five with
vegetative lesions involving the aortic valve and three with
lesions on the mitral valve. all proved at the time of surgery
or autopsy. From this study , they concluded that vegetations
of 2 rom or greater could be identified using M-mode echo-
cardiography. Four of their patients with endocarditis had
negative blood cultures . Although they stated that there does
not seem to be any problem in confusing the echocardio-
graphic signs of vegetation with the usual findings of a
thickened mitral or aortic valve. they did note that there
conceivably might be some confusion between the echo-
cardiograms of patients with vegetation and those with
myxomatous degeneration. Subsequent investigators (44-
48) have also recognized and reported on the usefulness of
M-mode echocardiography in the evaluation of the patient
with endocarditis .
Two-dimensional echocardiography is superior to M-mode
echocardiography in patients with infective endocarditis and
is particularly useful in patient s with prosthetic valves and
those with tricupsid valve endocarditis (49-52). It is su-
perior also in identifying the complications of endocarditis.
including intramyocardial abscesses and disruption of val-
vular tissue and valvular supporting tissue.
Diagnostic accuracy. The diagnostic value of echocar-
diography depends primarily on the demonstration of veg-
etations (Fig. I to 3). Various attempts have been made to
estimate the sensitivity, specificity and diagnostic accuracy
of this technique, based on the presence or absence of veg-
etation on cardiac valves (47.48 ,51-54). The reported prev-
alence of vegetation detected by echocardiography in pa-
tients with infective endocarditis has ranged from 13 to 78%
(53-55).
The frequency with which macroscopic vegetations occur
in cases of active infective endocarditis must also be con-
sidered. Autopsy studies have shown that vegetations occur
in 53% of patients who die of active infective endocarditis
(56,57). These autopsy cases obviously include patients who
experienced the lethal complications of vegetative endo-
carditis . All complications are known to occur more fre-
quently in patients with vegetations then in those without.
Therefore, the frequency with which vegetations are de-
tected echocardiographically may be less than 53%.
Limitations. If the study is performed in patients with
proved active endocarditis , then the sensitivity, specificity
and diagnostic accuracy of echocardiography will be im-
proved; however, the diagnostic value of the study will be
limited. Further, if the clinical diagnosis of infective en-
docarditis is known, then interpretation of the echocardi-
ographic findings may be biased toward the diagnosis of
vegetations (47,54) .
The ultrasonic characteristics of a vegetation affect its
echocardiographic detection. It is likely that some vege-
tations will have the same acoustical properties as the sur-
rounding tissue and therefore go undetected. The size of the
vegetation is equally important. Thompson et al. (53) re-
ported the detection of lesions as small as 1 mm, but these
lesions were calcified and a vegetation in its early state rarely
contains calcium. It is unlikely then that vegetations smaller
than 2 mm will be identified given the present resolution
characteristics of current echocardiographic equipment. The
instrument used and the skill of the echocardiographic tech-
nician are additional factors to be considered (50). The best
results are obtained by combining the M-mode and two-
dimensional techniques.
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Figure 1. Apex to base scan of a 36 year old man with
infective endocarditis involving a bicuspid aortic valve.
Note the enlarged left ventricular chamber (left) with dy-
namic wall motion, premature closure of the mitral valve
(long vertical arrow), the abnormal diastolic echoes in
the left ventricular outflow tract (identified by small ar-
rowheads), the abnormal echoes in the aortic root seen
during diastole (secondary to vegetation) and the enlarged
left atrium (right). (Reprinted with permission from Giu-
liani ER. Role of echocardiographic studies in the am-
bulatory patient. Cardiovasc Clin 1980;10:109.)
The patient plays a critical role in enhancing the effec-
tiveness of echocardiography. In the young patient who is
easily studied, a complete examination can be obtained in
most cases. However, in patients who are elderly, obese or
postoperative, or have chronic obstructive pulmonary dis-
ease or chest deformities, a complete ultrasonic cardiac ex-
Figure 2, A, Still frame of the left side of the heart on its long axis
demonstrating vegetations attached to the atrial surface of the anterior mitral
leaflet (large arrowhead, V). Note point of attachment of the vegetation
(small arrowheads). amI =anterior mitral leaflet: Ao =aorta; LA =left
atrium; LV = left ventricle; RV = right ventricle. In each illustration the
depth markings are given in centimeters. Arrow direction: A = anteriorly;
I =inferiorly; P =posteriorly; S =superiorly. B, M-mode scan from apex
to base of the heart of a patient with infective endocarditis involving the
mitral valve. Note shaggy echoes encompassing the anterior and posterior
mitral leaflets (arrows), both of which retained their normal motion pattern.
The left ventricle (LV) is dilated with good ventricular function. The left
atrium (LA) is enlarged. The electrocardiogram at the top of the tracing
is for reference. RV = right ventricle. (Reprinted from Giuliani ER, Nasser
FN [73]. with permission.)
amination is not possible. In these patients the frequency
of identification of vegetations will be smaller.
Preexisting valvular disease adds to the difficulty of the
examination. If the patient has underlying rheumatic val-
vular heart disease, it becomes difficult and often impossible
to differentiate vegetative lesions from the chronic under-
lying pathologic process. Many workers now have reported
on the difficulty of diagnosing endocarditis in patients who
have myxomatous valvular changes, particularly of the mi-
tral valve.
Patients who have had previous endocarditis also pose
a problem. Patients with echocardiographically demonstra-
ble vegetations are often cured of their infections. Experi-
ence has shown that although many of these vegetations
disappear, some persist and either become smaller or remain
the same size as judged by echocardiography.
Finally, the timing ofthe echocardiographic examination
in relation to the onset of the illness should be considered
(55). Although the minimal length of time required to de-
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Figure 3. Still frame of a four chamber view from the apical position
demonstrating tricuspid valve vegetation (small arrow, TVV). After this
study. the patient had a pulmonary embolus. Subsequent echocardiographic
studies demonstrated a marked reduction in the size of the vegetation.
AS = atrial septum; MV = mitral valve; VS = ventricular septum. Arrow
direction: L = left; R = right; other lettering as in Figure 2A.
velop an identifiable lesion by echocardiography is un-
known, studies have shown that a vegetation identifiable by
echocardiography is larger in patients with a longer duration
of symptoms than in those with a shorter duration of symp-
toms (58,59).
Despite these limitations, it is important to identify veg-
etations. The patients with active endocarditis in whom
valvular vegetations are detected represent a subset of pa-
tients whose clinical course is quite different from that of
patients who do not manifest this finding. Patients with
demonstrable vegetations have a higher rate of all
complications.
Valvular Incompetence
If valvular tissue is destroyed or supporting structures are
disrupted as a result of active endocarditis, the hemody-
namic consequence is valvular incompetence. The rate and
extent of tissue destruction will determine the severity of
valvular incompetence and the clinical course of the patient.
Patients tolerate incompetence of the right cardiac valves
quite well. The regurgitation that develops when left cardiac
valves are affected, particularly aortic valve incompetence,
is tolerated less well.
Aortic Valve Incompetence
Wray (46) described the diagnostic echocardiographic cri-
teria for disruption of the aortic valve. and these findings
can be demonstrated by both M-mode and two-dimensional
echocardiography. Pridie et al. (60) were the first to show
the importance of echocardiographic determination of early
mitral valve closure in patients with acute aortic incompe-
tence (Fig. 1). Others (47,61,62) have confirmed this find-
ing. Some workers believe that by itself the finding is an
indication for surgical intervention. Our experience supports
this opinion because our patients who demonstrated pre-
mature mitral valve closure either were in a clinically un-
stable condition or had refractory congestive heart failure
and, therefore, were candidates for aortic valve replace-
ment. Thus, in selected patients with aortic involvement,
the echocardiogram reflects the severity of the aortic valve
incompetence.
In the patient who is cured of active endocarditis but still
has chronic aortic valve incompetence. the echocardiogram
is useful because its data may be of prognostic value (63).
We have confirmed the findings of others that the M-mode
left ventriculogram is useful in predicting patient outcome
after replacement of the aortic valve (64). Patients who
demonstrate a change in left ventricular dimension greater
than 35% have a better prognosis than db patients whose
dimensional change is 30% or less (Fig. 4).
Mitral Valve Incompetence
Acute mitral valve incompetence due to active endocarditis
is most frequently caused by rupture of one or more chordae
tendineae to the mitral valve leaflets. Two-dimensional echo-
cardiography has allowed the documentation of this clinical
event (65), and can further support the clinical diagnosis
(66,67). Fortunately, many patients tolerate the insult of
acute mitral incompetence quite well and their course is like
that of any patient with nonrheumatic mitral valve incom-
petence. In this group of patients with chronic mitral in-
competence, serial echocardiographic examinations have
proved helpful in predicting which patients will do well
after mitral valve repair or replacement.
We studied 96 patients who had surgery for chronic mitral
valve incompetence. In this group, there was a higher 5
year mortality rate in patients with a left ventricular internal
systolic dimension (LV1Ds ) of more than 50 mm or a change
in diameter of less than 31% (Fig. 5). Atrial fibrillation.
which was related to larger left atrial dimensions, was also
associated with a poorer prognosis (68).
Myocardial Abscesses
The frequency of complication of myocardial abscesses is
unknown. Arnett and Roberts (69) reported 22 aortic ring
abscesses and 2 mitral ring abscesses in 74 patients who
died with infective endocarditis. A similar observation was
reported by Burnside and DeSanctis (70). Aortic ring ab-
scesses (Fig. 6 and 7) are detected more frequently by echo-
cardiography than are abscesses of the mitral ring. Although
these abscesses have been identified using the M-mode tech-
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intervention (75). The patient with infective endocarditis
and demonstrable vegetation presents a difficult manage-
ment problem that requires an individualized clinical decision.
Clinical Application
The application of echocardiography to patients with active
endocarditis has provided a better understanding of the nat-
ural course of the disease, enabled us to identify accurately
the complications of active infective endocarditis and per-
mitted us to separate a subset of patients at high risk of
complications and death. In patients cured of endocarditis
but with chronic valvular incompetence, the echocardiogram
contains data of prognostic value that may be helpful in
timing surgical intervention. The echocardiographic ex-
amination aids but does not allow the diagnosis of active
endocarditis, and should be used in combination with other
factors to determine the need for surgical therapy. The data
obtained by echocardiography, if integrated with the clinical
data and other laboratory data. can be and have been very
useful in the care of patients with infective endocarditis.
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Figure 4. Relation between probability of survival after valve replacement
for aortic insufficiency and preoperative percent change in left ventricular
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Indications for Cardiac Surgery
Congestive heart failure. Although infective endocar-
ditis is primarily managed with medical therapy. cardiac
surgery has played an important role in the past 12 to 15
years. Cardiac valve replacement has been lifesaving in
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Figure 5. Relation between the probability of survival after valve replace-
ment for mitral insufficiency and preoperative percent change of left ven-
tricular dimension (%6D). Patients with low values have a significantly
decreased probabilityof survival. Small numbers indicate numbersof patients.
nique (71), the two-dimensional technique is far superior
(72,73). Nakamura et al. (74) were the first to report the
echocardiographic appearance of mitral ring abscesses. We
have seen complications of intramyocardial abscess develop
in patients with involvement of the aortic, mitral and tri-
cuspid valves. This complication is found in about 10% of
our patients who have demonstrable valvular vegetations.
In our opinion, the demonstration of this complication is
not an indication for immediate surgical intervention; the
indications depend on the patient's clinical course, specif-
ically the status of the cardiovascular system.
Embolization
Finally, a major complication associated with endocarditis
is embolization. Although embolization occurs in patients
with or without demonstrable vegetation, its incidence is
significantly greater in patients with vegetation (55,58). In
our experience, embolization occurs in approximately one-
third of patients with proved bacterial endocarditis and echo-
cardiographically demonstrated vegetations involving the
left-sided cardiac valves. Embolization is more frequent if
vegetations involve the aortic valve as compared with the
mitral valve. Because of the large incidence of systemic
emboli, frequently to the cerebrovascular system, some phy-
sicians recommend cardiac surgery with valve replacement
in patients who have vegetation. In our opinion, the presence
of vegetation is not necessarily an indication for surgical
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Figure 6. A, Still frame of the long axis view of the left ventricle (LV)
in a patient who had infective endocarditis involving the aortic valve and
developed an aortic root abscess that dissected from the anterior root down
into the interventr icular septum (abs, small arrows) . AVV. arrow = aortic
valve vegetation; MY = mitral valve; PE = pericardialeffusion; PW = posterior
wall; other abbreviations as in Figure 2A. B, M-rnode scan from apex to
base of left ventricle in the same patient. Note the echo-free space (efs)
representing an aortic root abscess . Also note the thickened aortic leaflet
echoes in diastole. the dilated left ventricle (LV) with good systolic function
and the small pericardial effusion (pe) . Othe r abbreviatio ns as in Figure
2B. (Reprinted with permission from Nasser FN. Giuliani ER. Clinical
Two-Dimensional Echocardiography. Chicago: Year Book Medical. 1982.)
selected patients with infective endocarditis . This is partic-
ularly true in patients with intractable heart failure due to
destruction of valve tissue or its supporting structures (7 6-
83).
Congestive heart failure is the leading cause of death
among patients with infective endocarditis ( 17.84~7). With
this complication , the mortality rate is higher in patients
with aortic infective endocarditi s (40 to 93%) than in those
with mitral infective endocarditis (17 to 66 % ) (76 ). Among
patients with severe congestive heart failure complicating
infective endocarditis, the mortality rate is higher in those
treated medically than in those given medical therapy plus
cardiac valve replacement (76 ,77 .88- 91).
The indications f or cardiac surgery in patients with in-
fe ctive endocarditis are similar to those fo r patients with
valvular heart disease f rom other causes. An analysis of
patients who underwent ca rdiac valve replacement because
of heart failure due to infect ive endocarditis disclosed that
the operative mortality was closely related to the degree of
function al heart failure at the time of opera tion (92). The
overall mortality rate was higher in patients with class IV
disability (17%) than in patients with class III (7%) or II
(8%) disab ility , althou gh the difference was not stat isticall y
significant. The mortal ity rate for. pat ients with class IV
disability who had undergone aortic valve replacement was
significantly higher (22%) than that for patients with class
III (0) or 11 disability (6%. p = 0.01 ) (92). The operative
mortality rate was similar to that of patients without infect ive
endocardit is when the degree of heart failure was the same
at the time of operation .
In patients with severe class IV heart failure or with
sudden onset of severe aortic valve incompetence due to
infective endocarditis, prompt cardiac valve replacement
offers the best hope of survival. Thi s operation can be per-
formed successfully in patients with active infection , even
when blood cultures are positive in the immediate preop-
erative period (93). In this type of patient , delay to stabilize
the heart failure with medical treatment or to complete a
course of antimicrobial therap y commonly result s in death
from heart failure (93). The hemod ynamic status of pat ients
with infective endocarditis. rather than the activity of the
infection or the length of preoperati ve antimicrobial therapy.
should be the determining factor in the timing of cardiac
valve replacement.
Embolism. An infrequent, but important. additional group
of complications warrants surgical consideration in selected
cases. Echocardiography has played an important role in
sugges ting a need for surgical intervention . The greatest
frequency of major embolic events occurs in associa tion
with infections that produ ce large mobile vegetations. such
as Haemophilus parainfiuenzae and other slow-growing gram-
negative bacilli , fungi (especiall y aspergillus) and nutri-
tionally variant viridans streptococci (94.95). Patients with
no history of emboli or only a single embolic event who
have large valvular vegetations on the two-dimensional echo-
cardiogram are worri some, but these conditions by them-
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Figure 7. Still frame of the long axis view of the left side of the heart in
a young patient with aortic valve endocarditis whose complication of aortic
root abscess involved the posterior aortic root and dissected down into the
anterior mitral leaflet (arrows). ab = abscess; other abbreviations as in
Figure 2A.
selves do not usually seem to justify valve replacement at
the present time. If more than one embolic episode has
occurred in this circumstance, valve debridement or re-
placement is recommended by some clinicians (96,97). To
date, we have elected to make the decision in this situation
on an individual basis, depending on the microbiologic etiol-
ogy and the presence or absence of large mobile vegetations
on subsequent two-dimensional echocardiography after an
initial embolic event.
Abscesses. In early experiences with two-dimensional
echocardiography, large abscesses in the aortic root or sep-
tum that were occasionally encountered raised the question
of possible surgical intervention. In most of these patients,
the abscess decreased in size and eventually cleared with
antibiotic therapy alone.
Fungal endocarditis am} relapsing endocarditis.
Additional indications for valve replacement are found in
patients with fungal endocarditis. Such patients should undergo
cardiac valve replacement in combination with antifungal
therapy before, during and after operation (98). Staphylo-
coccal infective endocarditis may be cured medically in
some patients, but valve replacement is indicated if relapse
occurs. Patients with gram-negative bacillary endocarditis
may be allowed a second relapse before valve replacement
is undertaken, and patients with penicillin-sensitive viridans
and enterococcal infective endocarditis have been allowed
as many as three relapses before cardiac valve replacement
(99-101).
The rare patient who develops an aneurysm of the sinus
of Valsalva or atrioventricular junctional tissue will require
urgent surgery. A patient with infective endocarditis who
develops abrupt right-sided heart failure with a continuous
basal murmur should be suspected of having one of these
lesions (102).
Purulent pericarditis. This is a rare complication of
infective endocarditis. It is usually associated with staph-
ylococcal infective endocarditis, is detectable by two-di-
mensional echocardiography and requires prompt surgical
drainage and antimicrobial therapy. Pericardiectomy is nec-
essary in some patients.
Prosthetic valve endocarditis. Infective endocarditis
superimposed on prosthetic valves is difficult to manage.
With a sensitive organism and early treatment using appro-
priate antimicrobial agents, the infection may be eradicated.
Ifthe infection persists or relapse occurs, the infected valve
should be removed and treatment continued for 3 to 4 weeks
(102).
Tricuspid valve endocarditis. Patients with tricuspid
valve endocarditis present unique surgical problems. If the
infection is resistant to antibiotic agents, as is often true
with Pseudomonas and other gram-negative bacilli, fungi
and some other organisms, excision of the tricuspid valve
is the operation of choice. Absence of the tricuspid valve
may be well tolerated in patients who do not have pulmonary
hypertension (l03).
The role of surgery in the management of infective en-
docarditis has been clarified significantly during the past
quarter century, but in individual patients the question of
surgical intervention and its timing still may prove
troublesome.
Conclusion
Thus, in the past 25 years we have noted impressive ad-
vances in the management of patients with infective en-
docarditis. Improved bacteriologic techniques have allowed
the detection of cases of infective endocarditis due to un-
usual organisms. Bactericidal therapy has become available
for patients with gram-negative endocarditis and antimicro-
bial therapy has improved. Echocardiography has evolved
into an important diagnostic and management aid and car-
diac valve replacement has dramatically improved the out-
look for many patients.
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